Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Glutathione is a tripeptide compound, which is made from amino acids such as glycine, cysteine, and glutamic acid. Glutathione helps in preventing damage to important cellular components of human body, caused by reactive oxygen species such as free radicals, peroxides, lipid peroxides, and heavy metals. The global glutathione market is estimated to surpass US$ 361.0 million by the end of 2027 in terms of revenue, exhibiting a CAGR of 7.4% during the forecast period (2020 to 2027).
The increasing demand for nutricosmetics is expected to drive demand for glutathione over the forecast period. Nutricosmetics are oral-based nutritional supplements for beauty and skin health. Nutricosmetics market is primarily driven by the expansion and consumer awareness in personal grooming coupled with busy lifestyle of the growing urban population. Nutricosmetics are health products, which are mainly used for the treatment of hair, nail, skin defects, and sun protection. Some of the key drivers to fuel the nutricosmetics market include rising retail shops across the globe, rising popularity of ready to drink nutricosmetics beverages, preference for effective and safe beauty solutions boosts the sales of cosmetics supplements, and growing consumer awareness toward prevention of pre-mature skin aging along with others.
Among regions, Asia Pacific held dominant position in the global glutathione market in 2020, accounting for 36.0% market share in terms of revenue, followed by North America and Europe. The growth of the pharmaceutical sector in the region is expected to drive demand for glutathione over the forecast period. For instance, according to the India Brand Equity Foundation (IBEF), India’s domestic pharmaceutical market is expected to be valued at US$ 42 billion in 2021 and is expected to reach US$ 64 billion by 2024 and further estimated to reach ~US$ 120-130 billion by 2030.
Figure 1. Global Glutathione Market Revenue Share (%), By Region, 2019
Continuous consumption of synthetic glutathione such as supplements may alert the human body to stop its own production of glutathione resulting in dependence on synthetic supplements. Depletion of liver glutathione levels (the site of glutathione storage) may be devastating to health. This factor is expected to hamper the market growth of glutathione over the forecast period.
Glutathione Market Report Coverage
||Market Size in 2020:
||US$ 219.0 Mn
|Historical Data for:
||2017, 2018 and 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 361.0 Mn
- Regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
- By Product Type: Reduced Glutathione and Oxidized Glutathione
- By Application: Food & Beverages, Pharmaceuticals, Personal Care & Cosmetics and Others
Kyowa Hakko Bio Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping Genuine Biochemical Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and Jarrow Formulas, Inc.
- Increasing demand for nutricosmetics
- Increasing growth of pharmaceutical industry
|Restraints & Challenges:
- Health risk associated with consumption of glutathione
The increasing trend of online shopping due to the growing digital engagement of consumers as well as manufacturers that enable easy access to products through e-commerce channels is increasing sale of cosmetic products. For instance, according to the U.S. Department of Commerce, consumers spent US$ 601.75 billion online with the U.S. merchants in 2019, which is 14.9% up from US$ 523.64 billion in 2018. Thus, growing online shopping trend is expected to accelerate the market growth of glutathione.
Figure 2. Global Glutathione Market Revenue Share (%), By Application, 2019
On the basis of application, in 2020, pharmaceuticals segment accounted for 41.0% of the revenue share. Growth of the pharmaceutical sector is expected to drive demand for glutathione over the forecast period. For instance, according to The European Federation of Pharmaceutical Industries and Associations, in 2018, North America accounted for 48.9% of global pharmaceutical sales and Europe accounted 23.2% of the total sales.
Global Glutathione Market - Impact of Coronavirus (Covid-19) Pandemic
The COVID-19 pandemic has changed the buying pattern of consumers. Measures such as nationwide lockdown have led panic buying of food and hygiene products. Following the COVID-19 crisis, increasing number of patients are opting for self-medication rather than visiting a doctor. This has led to several people stocking up over-the-counter drugs for symptom relief. Moreover, awareness and interest in the role of preventive health among consumers, has increased demand for products which help in boosting the immunity. This has led to increasing demand for health supplements. The overall increase in demand for pharmaceuticals is expected to drive the market growth of glutathione during the pandemic.
Key players operating in the global glutathione market include Kyowa Hakko Bio Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping Genuine Biochemical Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and Jarrow Formulas, Inc.